Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris

被引:127
作者
Kakinuma, T
Saeki, H
Tsunemi, Y
Fujita, H
Asano, N
Mitsui, H
Tada, Y
Wakugawa, M
Watanabe, T
Torii, H
Komine, M
Asahina, A
Nakamura, K
Tamaki, K
机构
[1] Univ Tokyo, Dept Dermatol, Bunkyo Ku, Tokyo 1138655, Japan
[2] Fukushima Med Univ, Sch Med, Dept Dermatol, Fukushima, Japan
关键词
cutaneous T cell-attracting chemokine; CCL27; atopic dermatitis; psoriasis vulgaris; disease activity;
D O I
10.1067/mai.2003.114
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Both atopic dermatitis (AD) and psoriasis vulgaris (PsV) are characterized as chronic and relapsing inflammatory skin diseases associated with various immunologic abnormalities. Cutaneous T cell-attracting chemokine (CTACK; CCL27) is a member of the CC chemokine family and a functional ligand for CC chemokine receptor 10. It is selectively expressed in skin and attracts CC chemokine receptor 10-expressing skin-homing memory T cells. The epidermal keratinocyte is a main source of CTACK, suggesting the involvement of various inflammatory skin diseases. Objective: The purpose of this investigation was to clarify whether CTACK produced by keratinocytes is detected in the sera of patients with AD and PsV and to examine the correlation between the serum CTACK levels and disease activity of patients with AD and PsV. Methods: We measured the serum CTACK levels in 50 patients with AD, 30 patients with PsV, and 22 healthy control subjects. We also divided 50 patients with AD into 3 groups (ie, those with mild, moderate, and severe disease) and compared them among 3 categories. Moreover, we compared the serum CTACK levels of patients with AD and PsV with clinical or laboratory data. Immunohistochemical staining of CTACK and IFN-induced protein of 10 kd (IP-10; CXCL10) was performed on the lesional skin of patients with AD and PsV. Results: The serum CTACK levels in,patients with AD and PsV were significantly higher than those in healthy control subjects. The serum CTACK levels in patients with AD significantly correlated with scoring atopic dermatitis (SCORAD) scores, serum soluble IL-2 receptor levels, serum soluble E-selectin levels, serum thymus and activation-regulated chemokine levels, and serum macrophage-derived chemokine levels. Serum CTACK levels in patients with PsV significantly correlated with the serum IP-10 levels but not with the Psoriasis Area and Severity Index score. Immunohistochemical staining showed CTACK was strongly expressed in lesional keratinocytes of patients with AD and PsV, whereas IP-10 was strongly expressed in lesional keratinocytes of patients with PsV and focally in those with AD. Conclusion: These results suggest that CTACK might be one of the important chemokines for the pathogenesis of AD and PsV.
引用
收藏
页码:592 / 597
页数:6
相关论文
共 20 条
  • [11] ELEVATED LEVELS OF INTERLEUKIN-2 RECEPTOR IN SERA OF PATIENTS WITH ATOPIC-DERMATITIS AND PSORIASIS
    KAPP, A
    PISKORSKI, A
    SCHOPF, E
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1988, 119 (06) : 707 - 710
  • [12] Chemokines and the tissue-specific migration of lymphocytes
    Kunkel, EJ
    Butcher, EC
    [J]. IMMUNITY, 2002, 16 (01) : 1 - 4
  • [13] Clinical validation and guidelines for the SCORAD index: Consensus report of the European task force on atopic dermatitis
    Kunz, B
    Oranje, AP
    Labreze, L
    Stalder, JF
    Ring, J
    Taieb, A
    [J]. DERMATOLOGY, 1997, 195 (01) : 10 - 19
  • [14] Atopic dermatitis: New insights and opportunities for therapeutic intervention
    Leung, DYM
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (05) : 860 - 876
  • [15] CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells
    Morales, J
    Homey, B
    Vicari, AP
    Hudak, S
    Oldham, E
    Hedrick, J
    Orozco, R
    Copeland, NG
    Jenkins, NA
    McEvoy, LM
    Zlotnik, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (25) : 14470 - 14475
  • [16] CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin
    Reiss, Y
    Proudfoot, AE
    Power, CA
    Campbell, JJ
    Butcher, EC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (10) : 1541 - 1547
  • [17] SEVERITY SCORING OF ATOPIC-DERMATITIS - THE SCORAD INDEX - CONSENSUS REPORT OF THE EUROPEAN TASK-FORCE ON ATOPIC-DERMATITIS
    STALDER, JF
    TAIEB, A
    ATHERTON, DJ
    BIEBER, T
    BONIFAZI, E
    BROBERG, A
    CALZA, A
    COLEMAN, R
    DEPROST, Y
    DIEPGEN, TL
    GELMETTI, C
    GIANNETTI, A
    HARPER, J
    KUNZ, B
    LACHAPELLE, JM
    LANGELAND, T
    LEVER, R
    ORANJE, AP
    QUEILLEROUSSEL, C
    REVUZ, J
    RING, J
    ROUJEAU, JC
    SAURAT, JH
    SONG, M
    TENNSTEDT, D
    VANNESTE, D
    VIELUF, D
    PONCET, M
    [J]. DERMATOLOGY, 1993, 186 (01) : 23 - +
  • [18] The antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cells
    Stoof, TJ
    Flier, J
    Sampat, S
    Nieboer, C
    Tensen, CP
    Boorsma, DM
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (06) : 1114 - 1120
  • [19] PSORIASIS - A DISEASE OF ABNORMAL KERATINOCYTE PROLIFERATION INDUCED BY LYMPHOCYTES-T
    VALDIMARSSON, H
    BAKER, BS
    JONSDOTTIR, I
    FRY, L
    [J]. IMMUNOLOGY TODAY, 1986, 7 (09): : 256 - 259
  • [20] Soluble E-selectin as a marker of disease activity in atopic dermatitis
    Yamashita, N
    Kaneko, S
    Kouro, O
    Furue, M
    Yamamoto, S
    Sakane, T
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (03) : 410 - 416